82 related articles for article (PubMed ID: 8311483)
1. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal expression of glycoconjugate associated with the development of endometrial cancer: a basic study and its usefulness in clinical application].
Tsukazaki K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):789-801. PubMed ID: 8371008
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal expression of carbohydrate chain and its mechanism in endometrial cancer].
Kubushiro K; Tsukazaki K; Sakuma Y; Nozawa S
Nihon Rinsho; 1995 Jul; 53(7):1753-9. PubMed ID: 7630016
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies raised against cultured cells and their application in cancer diagnosis].
Nozawa S; Udagawa Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1858-63. PubMed ID: 2730079
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract][Full Text] [Related]
7. [Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3].
Tsukazaki K; Kobiki K; Hasegawa K; Sakayori M; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2476-83. PubMed ID: 1280307
[TBL] [Abstract][Full Text] [Related]
8. [Production of monoclonal antibody against a newly established human endometrial cancer cell line SNG-II].
Nozawa S; Sakayori M; Takayama Y; Tsukazaki K; Aoki D; Iizuka R; Mukai M; Inaba N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):559-66. PubMed ID: 3295079
[TBL] [Abstract][Full Text] [Related]
9. [Anti-endometrial cancer monoclonal antibody "MSN-1" and its application to EmC-EIA method].
Nozawa S; Tsukazaki K; Sakayori M; Kobayashi Y; Kobiki K
Rinsho Byori; 1993 Jun; Suppl 94():147-60. PubMed ID: 8361005
[No Abstract] [Full Text] [Related]
10. Involvement of H type 1 carbohydrate antigen in cell adhesion to vascular endothelial cells of human endometrial cancer.
Sakuma Y; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2003; 23(2B):1277-82. PubMed ID: 12820383
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a quantitative assay of abnormal glycolipid expression in endometrial cells, and its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Kubushiro K; Sakayori M; Nozawa S
Clin Cancer Res; 1996 Apr; 2(4):749-54. PubMed ID: 9816226
[TBL] [Abstract][Full Text] [Related]
12. [On the clinical usefulness of a few sugar antigens and a galactosyl-transferase].
Nozawa S; Izumi S; Sakayori M; Narisawa S; Kojima K; Iizuka R; Iwamori M; Nagai Y
Hum Cell; 1988 Mar; 1(1):37-45. PubMed ID: 3155288
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.
Nozawa S; Sakayori M; Ohta K; Iizuka R; Mochizuki H; Soma M; Fujimoto J; Hata J; Iwamori M; Nagai Y
Am J Obstet Gynecol; 1989 Oct; 161(4):1079-86. PubMed ID: 2478021
[TBL] [Abstract][Full Text] [Related]
14. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
Yudate T; Isaka K; Okabe K; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
[TBL] [Abstract][Full Text] [Related]
15. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
16. Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients.
Bartolazzi A; Mottolese M; Vocaturo A; Bigotti A; Vocaturo G; Atlante G; Prat M; Natali PG
Cancer Res; 1991 Jun; 51(11):3001-5. PubMed ID: 2032237
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the expression of the antigen recognized by monoclonal antibody MSN-1 in endometrial hyperplasia which progressed to endometrial cancer].
Tsukazaki K; Kobayashi Y; Yoshida N; Sakayori M; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):241-2. PubMed ID: 1372033
[No Abstract] [Full Text] [Related]
20. [The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri].
Ławicki S; Bedkowska GE; Gacuta-Szumarska E; Czygier M; Szmitkowski M
Pol Merkur Lekarski; 2009 Jun; 26(156):609-15. PubMed ID: 19711726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
